Evidence map›Paper›PMID 22046416›Full record

ArticlePloS one2011

Epilepsy caused by an abnormal alternative splicing with dosage effect of the SV2A gene in a chicken model.

Marine Douaud, Katia Feve, Fabienne Pituello, David Gourichon, Simon Boitard, Eric Leguern, Gérard Coquerelle, Agathe Vieaud, Cesira Batini, Robert Naquet and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Connectivity Mapping Using a NovelFrontiers in molecular neuroscience · 2022
    Article
  12. AEpilepsy & behavior reports · 2021
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Reflex epilepsy: triggers and management strategies.Neuropsychiatric disease and treatment · 2018
    Review
  19. Origins of Knowledge: Insights from Precocial Species.Frontiers in behavioral neuroscience · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Marine DouaudINRA-ENVT, Laboratoire de Génétique Cellulaire, Castanet-Tolosan, France.
Katia Feve
Fabienne Pituello
David Gourichon
Simon Boitard
Eric Leguern
Gérard Coquerelle
Agathe Vieaud
Cesira Batini
Robert Naquet
Alain Vignal
Michèle Tixier-Boichard
Frédérique Pitel
Laboratoire de Génétique Cellulaire · FRInstitut National de la Recherche Agronomique · MABiologie des Oiseaux et Aviculture · FRCentre de Biologie du Développement · FRCentre National de la Recherche Scientifique · FRInserm · FRLaboratoire de Microbiologie et Génétique Moléculaires · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Photosensitive reflex epilepsy is caused by the combination of an individual's enhanced sensitivity with relevant light stimuli, such as stroboscopic lights or video games. This is the most common reflex epilepsy in humans; it is characterized by the photoparoxysmal response, which is an abnormal electroencephalographic reaction, and seizures triggered by intermittent light stimulation. Here, by using genetic mapping, sequencing and functional analyses, we report that a mutation in the acceptor site of the second intron of SV2A (the gene encoding synaptic vesicle glycoprotein 2A) is causing photosensitive reflex epilepsy in a unique vertebrate model, the Fepi chicken strain, a spontaneous model where the neurological disorder is inherited as an autosomal recessive mutation. This mutation causes an aberrant splicing event and significantly reduces the level of SV2A mRNA in homozygous carriers. Levetiracetam, a second generation antiepileptic drug, is known to bind SV2A, and SV2A knock-out mice develop seizures soon after birth and usually die within three weeks. The Fepi chicken survives to adulthood and responds to levetiracetam, suggesting that the low-level expression of SV2A in these animals is sufficient to allow survival, but does not protect against seizures. Thus, the Fepi chicken model shows that the role of the SV2A pathway in the brain is conserved between birds and mammals, in spite of a large phylogenetic distance. The Fepi model appears particularly useful for further studies of physiopathology of reflex epilepsy, in comparison with induced models of epilepsy in rodents. Consequently, SV2A is a very attractive candidate gene for analysis in the context of both mono- and polygenic generalized epilepsies in humans.

Indexed as

Gene DosageAlternative SplicingAnimalsChickensDisease Models, AnimalEpilepsyHumansMembrane GlycoproteinsMiceMice, KnockoutMutationNerve Tissue ProteinsPhylogenySeizuresMembrane GlycoproteinsNerve Tissue ProteinsSv2a protein, mouse

Identifiers

PMID22046416
PMCPMC3203167
OpenAlexW2095418752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.